 Connection
Amrut Ambardekar to Benzoxazoles
This is a "connection" page, showing publications Amrut Ambardekar has written about Benzoxazoles.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.115 |
|
|
|
-
Abovich A, Fontana M, Claggett B, Gillmore JD, Cappelli F, Ambardekar AV, Morbach C, Garcia-Pavia P, Witteles RM, Maurer MS, Jay PY, Kosheleff A, Bansilal S, Solomon SD. Influence of Disease-Modifying Therapy on the Efficacy of Vutrisiran in Transthyretin Cardiac Amyloidosis. J Am Coll Cardiol. 2026 Sep 22; 88(12):1416-1424.
Score: 0.061
-
Judge DP, Gillmore JD, Alexander KM, Ambardekar AV, Cappelli F, Fontana M, García-Pavía P, Grodin JL, Grogan M, Hanna M, Masri A, Nativi-Nicolau J, Obici L, Hvitfeldt Poulsen S, Sarswat N, Shah K, Soman P, Lystig T, Cao X, Wang K, Pecoraro ML, Tamby JF, Katz L, Sinha U, Fox JC, Maurer MS. Long-Term Efficacy and Safety of Acoramidis in ATTR-CM: Initial Report From the Open-Label Extension of the ATTRibute-CM Trial. Circulation. 2025 Mar 04; 151(9):601-611.
Score: 0.054
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|